Search Results for "Combivent"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Combivent. Results 1 to 5 of 5 total matches.
See also: albuterol, ipratropium
Safety of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (COPD)
The Medical Letter on Drugs and Therapeutics • May 31, 2010 (Issue 1339)
anticholinergic such as ipratropium (Atrovent HFA,
and others), or sometimes both (Combivent). When
symptoms ...
Two combinations of an inhaled corticosteroid with an inhaled long-acting beta2-agonist are approved by the
FDA for use in patients with COPD: fluticasone/salmeterol (Advair Diskus) and budesonide/formoterol
(Symbicort). A Medical Letter reader has questioned the safety of using corticosteroid inhalers in patients
with this disorder. No single-agent inhaled corticosteroid inhaler is approved for this indication.
Table: Correct Use of Inhalers for COPD (online only)
The Medical Letter on Drugs and Therapeutics • Sep 07, 2020 (Issue 1606)
-daily dosing
Combivent Respimat (ipratropium/albuterol):
www.accessdata.fda.gov/drugsatfda_docs/label ...
View the Table: Correct Use of Inhalers for COPD
Comparison Table: Inhaled Drugs for Treatment of COPD (online only)
The Medical Letter on Drugs and Therapeutics • Sep 02, 2024 (Issue 1710)
Short-Acting Beta2-Agonist/Short-Acting Anticholinergic Combination
Albuterol/ipratropium –
Combivent ...
View the Comparison Table: Inhaled Drugs for Treatment of COPD
Med Lett Drugs Ther. 2024 Sep 2;66(1710):e143-7 doi:10.58347/tml.2024.1710b | Show Introduction Hide Introduction
Comparison Chart: Correct Use of Inhalers for Asthma (online only)
The Medical Letter on Drugs and Therapeutics • Nov 25, 2024 (Issue 1716)
with a damp cloth or tissue at least once/week
▶ Once-daily dosing
▶ Combivent Respimat (ipratropium ...
View the Comparison Chart: Correct Use of Inhalers for Asthma
Med Lett Drugs Ther. 2024 Nov 25;66(1716):e196-8 doi:10.58347/tml.2024.1716c | Show Introduction Hide Introduction
Drugs for COPD
The Medical Letter on Drugs and Therapeutics • Sep 02, 2024 (Issue 1710)
– Combivent Respimat 100 mcg/20 mcg/inh SMI (120 inh/unit) 1 inh qid PRN 489.306
(Boehringer Ingelheim ...
The main goals of treatment of chronic obstructive
pulmonary disease (COPD) are to relieve symptoms,
reduce the frequency and severity of exacerbations,
prevent disease progression, and reduce mortality.
GOLD (Global Initiative for Chronic Obstructive Lung
Disease) guidelines for treatment of COPD were
updated recently. Treatment of acute exacerbations
is not discussed here. Drugs available for treatment
of COPD are listed in Tables 1 and 3.
Med Lett Drugs Ther. 2024 Sep 2;66(1710):137-44 doi:10.58347/tml.2024.1710a | Show Introduction Hide Introduction